PTCH1 and melanoma: Effects of iRF on melanoma cells (B16F10 cells) are, at least in part, correlated with inhibition of HH signaling, as evident by the decreased the expression of key players in HH pathway signaling such as GLI1 and PTCH-1 and the increase of SUFU expression.